These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 23339869)
1. TRIP6 regulates p27 KIP1 to promote tumorigenesis. Lin VT; Lin VY; Lai YJ; Chen CS; Liu K; Lin WC; Lin FT Mol Cell Biol; 2013 Apr; 33(7):1394-409. PubMed ID: 23339869 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of TRIP6 promotes tumor proliferation and reverses cell adhesion-mediated drug resistance (CAM-DR) via regulating nuclear p27(Kip1) expression in non-Hodgkin's lymphoma. Miao X; Xu X; Wu Y; Zhu X; Chen X; Li C; Lu X; Chen Y; Liu Y; Huang J; Wang Y; He S Tumour Biol; 2016 Jan; 37(1):1369-78. PubMed ID: 26298725 [TBL] [Abstract][Full Text] [Related]
3. LIM domain only 2 induces glioma invasion via cytosolic p27(KIP1). Park CG; Sohn YW; Kim EJ; Kim SH; Kim SC; Kim H Tumour Biol; 2016 Feb; 37(2):2473-80. PubMed ID: 26383528 [TBL] [Abstract][Full Text] [Related]
4. TRIP6: an adaptor protein that regulates cell motility, antiapoptotic signaling and transcriptional activity. Lin VT; Lin FT Cell Signal; 2011 Nov; 23(11):1691-7. PubMed ID: 21689746 [TBL] [Abstract][Full Text] [Related]
5. Characterization of TRIP6-dependent nasopharyngeal cancer cell migration. Fei J; Li J; Shen S; Zhou W Tumour Biol; 2013 Aug; 34(4):2329-35. PubMed ID: 23576104 [TBL] [Abstract][Full Text] [Related]
6. The adaptor protein TRIP6 antagonizes Fas-induced apoptosis but promotes its effect on cell migration. Lai YJ; Lin VT; Zheng Y; Benveniste EN; Lin FT Mol Cell Biol; 2010 Dec; 30(23):5582-96. PubMed ID: 20876301 [TBL] [Abstract][Full Text] [Related]
7. YAP promotes the proliferation of neuroblastoma cells through decreasing the nuclear location of p27 Shen X; Xu X; Xie C; Liu H; Yang D; Zhang J; Wu Q; Feng W; Wang L; Du L; Xuan L; Meng C; Zhang H; Wang W; Wang Y; Xie T; Huang Z Cell Prolif; 2020 Feb; 53(2):e12734. PubMed ID: 31863533 [TBL] [Abstract][Full Text] [Related]
8. p27 Kip1 nuclear localization and cyclin-dependent kinase inhibitory activity are regulated by glycogen synthase kinase-3 in human colon cancer cells. Wang Q; Zhou Y; Wang X; Evers BM Cell Death Differ; 2008 May; 15(5):908-19. PubMed ID: 18408738 [TBL] [Abstract][Full Text] [Related]
9. TRIP6 enhances lysophosphatidic acid-induced cell migration by interacting with the lysophosphatidic acid 2 receptor. Xu J; Lai YJ; Lin WC; Lin FT J Biol Chem; 2004 Mar; 279(11):10459-68. PubMed ID: 14688263 [TBL] [Abstract][Full Text] [Related]
10. Calpain 2 regulates Akt-FoxO-p27(Kip1) protein signaling pathway in mammary carcinoma. Ho WC; Pikor L; Gao Y; Elliott BE; Greer PA J Biol Chem; 2012 May; 287(19):15458-65. PubMed ID: 22427650 [TBL] [Abstract][Full Text] [Related]
11. Hippo Signaling Suppresses Cell Ploidy and Tumorigenesis through Skp2. Zhang S; Chen Q; Liu Q; Li Y; Sun X; Hong L; Ji S; Liu C; Geng J; Zhang W; Lu Z; Yin ZY; Zeng Y; Lin KH; Wu Q; Li Q; Nakayama K; Nakayama KI; Deng X; Johnson RL; Zhu L; Gao D; Chen L; Zhou D Cancer Cell; 2017 May; 31(5):669-684.e7. PubMed ID: 28486106 [TBL] [Abstract][Full Text] [Related]
12. p27(Kip1) signaling: Transcriptional and post-translational regulation. Hnit SS; Xie C; Yao M; Holst J; Bensoussan A; De Souza P; Li Z; Dong Q Int J Biochem Cell Biol; 2015 Nov; 68():9-14. PubMed ID: 26279144 [TBL] [Abstract][Full Text] [Related]
13. Reduction of cytosolic p27(Kip1) inhibits cancer cell motility, survival, and tumorigenicity. Wu FY; Wang SE; Sanders ME; Shin I; Rojo F; Baselga J; Arteaga CL Cancer Res; 2006 Feb; 66(4):2162-72. PubMed ID: 16489017 [TBL] [Abstract][Full Text] [Related]
14. PTPL1/FAP-1 negatively regulates TRIP6 function in lysophosphatidic acid-induced cell migration. Lai YJ; Lin WC; Lin FT J Biol Chem; 2007 Aug; 282(33):24381-7. PubMed ID: 17591779 [TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor upregulates Skp2/Cks1 and p27(kip1) in human extrahepatic cholangiocarcinoma cells. Kim JY; Kim HJ; Park JH; Park DI; Cho YK; Sohn CI; Jeon WK; Kim BI; Kim DH; Chae SW; Sohn JH World J Gastroenterol; 2014 Jan; 20(3):755-73. PubMed ID: 24574749 [TBL] [Abstract][Full Text] [Related]
16. TRIP6 promotes cell proliferation in hepatocellular carcinoma via suppression of FOXO3a. Zhao W; Dai Y; Dai T; Xie T; Su X; Li J; Zhou X; Meng K; Zhao X Biochem Biophys Res Commun; 2017 Dec; 494(3-4):594-601. PubMed ID: 29080747 [TBL] [Abstract][Full Text] [Related]
17. Trip6 promotes dendritic morphogenesis through dephosphorylated GRIP1-dependent myosin VI and F-actin organization. Lv K; Chen L; Li Y; Li Z; Zheng P; Liu Y; Chen J; Teng J J Neurosci; 2015 Feb; 35(6):2559-71. PubMed ID: 25673849 [TBL] [Abstract][Full Text] [Related]
18. TRIP6 accelerates the proliferation and invasion of cervical cancer by upregulating oncogenic YAP signaling. Yang F; Li L; Zhang J; Zhang J; Yang L Exp Cell Res; 2020 Nov; 396(1):112248. PubMed ID: 32853630 [TBL] [Abstract][Full Text] [Related]
19. c-Src-mediated phosphorylation of TRIP6 regulates its function in lysophosphatidic acid-induced cell migration. Lai YJ; Chen CS; Lin WC; Lin FT Mol Cell Biol; 2005 Jul; 25(14):5859-68. PubMed ID: 15988003 [TBL] [Abstract][Full Text] [Related]
20. Sulforaphane down-regulates SKP2 to stabilize p27(KIP1) for inducing antiproliferation in human colon adenocarcinoma cells. Chung YK; Chi-Hung Or R; Lu CH; Ouyang WT; Yang SY; Chang CC J Biosci Bioeng; 2015 Jan; 119(1):35-42. PubMed ID: 25070589 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]